Read the latest positive news, breakthroughs, and inspiring stories about celiac disease, curated daily by BrightWire.
An experimental drug called ANB033 prevented gut damage and symptoms in celiac disease patients who ate gluten during a small trial. Only 6% of treated patients needed symptom relief compared to 47% who received a placebo.
Spanish scientists have created a molecule that breaks down gluten in the stomach, potentially freeing millions of celiac patients from strict gluten-free diets. The breakthrough works at very low doses where previous solutions failed.
The Celiac Disease Foundation just launched a $15 million fund to speed up breakthrough solutions for a condition affecting three million Americans, most of whom don't even know they have it. This investment could finally close the gap between patients and the life-changing answers they need.